Bruce Colwill
2022
In 2022, Bruce Colwill earned a total compensation of $295.2K as Former Chief Financial Officer at InMed Pharmaceuticals, a 43% decrease compared to previous year.
Compensation breakdown
| Option Awards | $50,496 |
|---|---|
| Salary | $244,683 |
| Total | $295,179 |
Colwill received $244.7K in salary, accounting for 83% of the total pay in 2022.
Colwill also received $50.5K in option awards.
Rankings
In 2022, Bruce Colwill's compensation ranked 5,055th out of 5,669 executives tracked by ExecPay. In other words, Colwill earned more than 10.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,055 out of 5,669 | 11th |
Division Manufacturing | 2,782 out of 3,081 | 10th |
Major group Chemicals And Allied Products | 1,295 out of 1,396 | 7th |
Industry group Drugs | 1,216 out of 1,297 | 6th |
Industry Pharmaceutical Preparations | 881 out of 940 | 6th |
Source: SEC filing on October 28, 2022.
Colwill's colleagues
We found four more compensation records of executives who worked with Bruce Colwill at InMed Pharmaceuticals in 2022.
2022
Eric Adams
InMed Pharmaceuticals
Chief Executive Officer
2022
Michael Woudenberg
InMed Pharmaceuticals
Chief Operating Officer
2022
Alexandra Mancini
InMed Pharmaceuticals
Senior Vice President, Clinical & Regulatory Affairs
2022
Eric Hsu
InMed Pharmaceuticals